WO1999024589B1 - Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung - Google Patents
Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendungInfo
- Publication number
- WO1999024589B1 WO1999024589B1 PCT/DE1998/003287 DE9803287W WO9924589B1 WO 1999024589 B1 WO1999024589 B1 WO 1999024589B1 DE 9803287 W DE9803287 W DE 9803287W WO 9924589 B1 WO9924589 B1 WO 9924589B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteins
- peptides
- lysozyme
- amino acids
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98963336A EP1029061A2 (de) | 1997-11-05 | 1998-10-31 | Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung |
AU18679/99A AU751422B2 (en) | 1997-11-05 | 1998-10-31 | Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof |
NZ504368A NZ504368A (en) | 1997-11-05 | 1998-10-31 | Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof |
JP2000520583A JP2002503443A (ja) | 1997-11-05 | 1998-10-31 | 抗微生物活性を持つリゾチーム類似タンパク質とペプチド、それらの生産および使用 |
IL13598798A IL135987A0 (en) | 1997-11-05 | 1998-10-31 | Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same |
CA002308618A CA2308618A1 (en) | 1997-11-05 | 1998-10-31 | Lysozyme-analogous proteins and peptides with an anti-microbial effect, their production and use |
US09/567,563 US6515106B1 (en) | 1997-11-05 | 2000-05-05 | Lysozyme-analogous polypeptides with an anti-microbial effect, their production and use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19749973A DE19749973C1 (de) | 1997-11-05 | 1997-11-05 | Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung |
DE19749973.2 | 1997-11-05 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/567,563 Continuation US6515106B1 (en) | 1997-11-05 | 2000-05-05 | Lysozyme-analogous polypeptides with an anti-microbial effect, their production and use |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1999024589A2 WO1999024589A2 (de) | 1999-05-20 |
WO1999024589A3 WO1999024589A3 (de) | 1999-11-04 |
WO1999024589B1 true WO1999024589B1 (de) | 2000-02-03 |
Family
ID=7848391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1998/003287 WO1999024589A2 (de) | 1997-11-05 | 1998-10-31 | Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung |
Country Status (9)
Country | Link |
---|---|
US (1) | US6515106B1 (de) |
EP (1) | EP1029061A2 (de) |
JP (1) | JP2002503443A (de) |
AU (1) | AU751422B2 (de) |
CA (1) | CA2308618A1 (de) |
DE (1) | DE19749973C1 (de) |
IL (1) | IL135987A0 (de) |
NZ (1) | NZ504368A (de) |
WO (1) | WO1999024589A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19749973C1 (de) * | 1997-11-05 | 1998-10-22 | Klaus Dr Duering | Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung |
JP5414972B2 (ja) * | 2003-12-23 | 2014-02-12 | バイオキット, エセ.アー. | 病原体感染の検出のための組成物および方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0155190A3 (de) * | 1984-03-16 | 1987-08-19 | Genentech, Inc. | Nicht in der Natur vorkommende Zymogene und Verfahren und Materialien zu deren Herstellung |
IT1190433B (it) * | 1985-12-11 | 1988-02-16 | Prodotti Antibiotici Spa | Peptidi correlati al lisozima |
AU2802989A (en) * | 1987-11-02 | 1989-06-01 | Louisiana State University Agricultural And Mechanical College | Plants genetically enhanced for disease resistance |
AU5433190A (en) * | 1989-04-10 | 1990-11-16 | Louisiana State University And Agricultural And Mechanical College | Lytic peptides, use for growth, infection and cancer |
DE3926390A1 (de) * | 1989-08-10 | 1991-02-14 | Bayer Ag | Verwendung von lysozym genen in pflanzen zur resistenzerhoehung |
US5422108A (en) * | 1991-09-19 | 1995-06-06 | Smart Plants International Inc. | Protection of plants against plant pathogens |
US5607914A (en) * | 1993-01-13 | 1997-03-04 | Pioneer Hi-Bred International, Inc. | Synthetic antimicrobial peptides |
DE19749973C1 (de) * | 1997-11-05 | 1998-10-22 | Klaus Dr Duering | Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung |
-
1997
- 1997-11-05 DE DE19749973A patent/DE19749973C1/de not_active Expired - Fee Related
-
1998
- 1998-10-31 NZ NZ504368A patent/NZ504368A/xx unknown
- 1998-10-31 WO PCT/DE1998/003287 patent/WO1999024589A2/de not_active Application Discontinuation
- 1998-10-31 JP JP2000520583A patent/JP2002503443A/ja active Pending
- 1998-10-31 CA CA002308618A patent/CA2308618A1/en not_active Abandoned
- 1998-10-31 EP EP98963336A patent/EP1029061A2/de not_active Withdrawn
- 1998-10-31 AU AU18679/99A patent/AU751422B2/en not_active Ceased
- 1998-10-31 IL IL13598798A patent/IL135987A0/xx unknown
-
2000
- 2000-05-05 US US09/567,563 patent/US6515106B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2308618A1 (en) | 1999-05-20 |
IL135987A0 (en) | 2001-05-20 |
NZ504368A (en) | 2002-11-26 |
DE19749973C1 (de) | 1998-10-22 |
JP2002503443A (ja) | 2002-02-05 |
EP1029061A2 (de) | 2000-08-23 |
US6515106B1 (en) | 2003-02-04 |
WO1999024589A2 (de) | 1999-05-20 |
WO1999024589A3 (de) | 1999-11-04 |
AU1867999A (en) | 1999-05-31 |
AU751422B2 (en) | 2002-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69829577T2 (de) | Mehrfach substituierte proteasevarianten | |
Ohashi et al. | Molecular Cloning of cDNA and Analysis of Expression of the Gene for α-Glucosidase from the Hypopharyngeal Gland of the HoneybeeApis melliferaL. | |
EP3181578B1 (de) | Carrier zum targeting von nervenzellen | |
EP0845972B1 (de) | Verwendung von mutierter subtilisin-protease in kosmetischen produkten | |
EP0602688B1 (de) | Methioninfreier G-CSF aus Prokaryonten | |
EP0746612B1 (de) | Synthetische polynukleotide | |
GB8826446D0 (en) | Peptide production | |
Steinborner et al. | New caerin antibacterial peptides from the skin glands of the Australian tree frog Litoria xanthomera | |
EP0228018B1 (de) | GM-CSF-Protein, seine Derivate, Herstellung solcher Proteine und ihre Verwendung | |
CA2063400A1 (en) | Inhibition of the n-end rule pathway in living cells | |
AU7891498A (en) | Flower organ-specific gene and its promoter sequence | |
EP0288809A1 (de) | Bifunktionelle Proteine | |
RU97110067A (ru) | Модифицированные ингибиторы протеиназы | |
AU653526B2 (en) | Novel signal sequences | |
DE10026998A1 (de) | Verfahren zur Herstellung einer kosmetischen Zusammensetzung, die humanes Serum Albumin umfasst, welches aus transgenen nicht-menschlichen Säugern erhalten wurde | |
ATE268383T1 (de) | Interferon gene aus voegeln und rekombinante dna | |
WO1999024589B1 (de) | Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung | |
Butler et al. | Current progress in the production of recombinant human fibrinogen in the milk of transgenic animals | |
EP0652903A1 (de) | Neues menschliches, rekombinantes interferon gamma | |
WO1995032297B1 (en) | Novel chromosome fragment and its use as a vector | |
DE69310540T2 (de) | Verhindern von spaltung von n-terminalen aminosäuren durch endogene aminopeptidasen während die expression von fremden genen in bakterien | |
WO1992020800A1 (en) | Plant pathogenesis-related proteins | |
DE60125386T2 (de) | Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins | |
EP0285675A1 (de) | Synthetische DNA-Kassetten mit Kodierung fuer artifizielle Proteine und deren Expression | |
EP0759473A1 (de) | Deletiertes Lysostaphingen von Staphylococcus Simulans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 135987 Country of ref document: IL |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA IL JP NZ US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA IL JP NZ US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: B1 Designated state(s): AU CA IL JP NZ US |
|
AL | Designated countries for regional patents |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2308618 Country of ref document: CA Kind code of ref document: A Ref document number: 2308618 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 504368 Country of ref document: NZ Ref document number: 09567563 Country of ref document: US Ref document number: 18679/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998963336 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998963336 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 18679/99 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998963336 Country of ref document: EP |